orally active covalent menin-MLL PPI inhibitor

efficacy in xenograft (300 mpk PO QD)

warhead addition to rev. inh. and opt.

Journal of Medicinal Chemistry

University of Michigan, Ann Arbor, US

9. The University of Michigan menin-MLL inhibitor, M-1121, is a covalent protein-protein interaction inhibitor that is orally active and achieves complete tumor regression in a xenograft model (300 mpk…

 this content is exclusive to
Premium members

Unlock this content with a Premium membership to read it now.